ITL BioMedical has launched patented DonorCare Needle Guard 2 that at the American Association of Blood Banks (AABB) Annual Meeting in Orlando, Florida, the event for healthcare professionals in transfusion medicine and cellular therapies.
ITL has been selling the first generation DonorCare Needle Guard for over 15 years and has sold in excess of 200 million units in over 50 countries.
First generation DonorCare Needle Guard set a global industry standard for whole blood collection needle guards.
The highly innovative DonorCare Needle Guard 2 provides robust functionality with enhanced features including visual confirmation that the needle is safely locked in place, along with an audible click.
The DonorCare Needle Guard 2 is designed for safe and fast needle withdrawal, immediately shielding the whole blood collection needle in a secure, one-piece housing thereby reducing potential exposure to needle stick injury.
Featuring a simple and user-friendly design, the product requires minimal training and can be easily incorporated into existing processes.
ITL BioMedical's efficient product design enables manufacturers to pre-attach DonorCare Needle Guard 2 onto blood bag tubing.
Bill Mobbs, Executive Chairman of ITL BioMedical commented, "It is very rewarding to take a global industry standard product up to the next level.
“As with all of our innovative products, DonorCare Needle Guard 2 was designed with end user input from the beginning, and we feel confident this product will be as successful as its predecessor."
ITL BioMedical is a division of ITL that sets industry standards for the innovative design and production of biological sampling systems for human and animal use.
The Division's patented medical devices focus on safety and process efficiency for end-users and their blood donors and patients in blood collection centers and healthcare markets worldwide.